Abstract
Specific environmental factors including chemicals, drugs, microbes, and both physical and psychological factors can affect the immune system producing dysfunction and, ultimately, an increased risk of chronic disease. Several different types of immune alterations can result from environmentally induced immunotoxicity and these connect immune insult to chronic disease. We illustrate how many immune-based chronic diseases arising in nonlymphoid tissues may be categorized based on the target tissue (e.g., skin, lung) rather than on the probable cause: a dysfunctional immune system. Finally, we discuss various factors that affect: (1) susceptibility to immunotoxicity and (2) the specific spectrum of disease outcomes following exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal R, Wisniewski JA, Woodfolk JA (2011) The role of regulatory T cells in atopic dermatitis. Curr Probl Dermatol 41:112–124
American Autoimmune Related Diseases Association (AARDA) (2010) A briefing report on autoimmune disease and AARDA: past, present and future. American Autoimmune Related Diseases Association, Eastpointe, MI
American Autoimmune Related Diseases Association (AARDA) (2011) The cost burden of autoimmune disease: the latest front in the war on healthcare spending. American Autoimmune Related Diseases Association, Eastpointe, MI. http://www.aarda.org/pdf/cbad.pdf
Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P (2000) Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406(6797):739–742
Beaglehole R, Ebrahim S, Reddy S, Voûte J, Leeder S, Chronic Disease Action Group (2007) Prevention of chronic diseases: a call to action. Lancet 370(9605):2152–2157
Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ (2011) Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 131(9):1853–1860
Bridges SL (2004) Update on autoantibodies in rheumatoid arthritis. Curr Rheumatol Rep 6(5):343–350
Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378(9795):1015–1026
Bucy RP, Xu XY, Li J, Huang G (1993) Cyclosporin A-induced autoimmune disease in mice. J Immunol 151(2):1039–1050
Chang SS, Weiss CO, Xue QL, Fried LP (2012) Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 54(1):9–15
Chen Z, Boreham J (2002) Smoking and cardiovascular disease. Semin Vasc Med 2(3):243–252
Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13(7):851–856
Cole JE, Mitra AT, Monaco C (2010) Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Expert Rev Cardiovasc Ther 8(11):1619–1635
Collins P, Vitale C, Spoletini I, Barbaro G (2011) Gender differences in the clinical presentation of heart disease. Curr Pharm Des 17(11):1056–1058
Corwin EJ, McCoy CS, Whetzel CA, Ceballos RM, Klein LC (2006) Risk indicators of metabolic syndrome in young adults: a preliminary investigation on the influence of tobacco smoke exposure and gender. Heart Lung 35(2):119–129
D’Mello C, Swain MG (2011) Liver-brain inflammatory axis. Am J Physiol Gastrointest Liver Physiol 301:G749–G761
Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, Galgani S, Martinelli V, Comi G, Avolio C, Martino G, Borsellino G, Sallusto F, Battistini L, Furlan R (2011) T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS One 6(6):e21386
de Vries JE (1994) Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J Invest Dermatol 102(2):141–144
de Vries JE, Yssel H (1996) Modulation of the human IgE response. Eur Respir J Suppl 22:58s–62s
Denkers EY (2010) Toll-like receptor initiated host defense against Toxoplasma gondii. J Biomed Biotechnol 2010:737125
DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR (2011) Current status of developmental immunotoxicity: early-life patterns and testing. Toxicol Pathol 40(2):230–236
Dietert RR (2008) Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol 5(4):401–412
Dietert RR (2009) Developmental immunotoxicology: focus on health risks. Chem Res Toxicol 22(1):17–23
Dietert RR (2011a) Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod Toxicol 31(3):319–326
Dietert RR (2011b) Maternal and childhood asthma: risk factors, interactions, and ramifications. Reprod Toxicol 32(2):198–204
Dietert RR, Piepebrink MS (2006) Lead and immune function. Crit Rev Toxicol 35:359–385
Dietert RR, Zelikoff JT (2009) Pediatric immune dysfunction and health risks following early-life immune insult. Curr Pediatr Rev 5:36–51
Dietert RR, DeWitt JC, Germolec DR, Zelikoff JT (2010) Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives. Environ Health Perspect 118(8):1091–1099
Doherty SP, Grabowski J, Hoffman C, Ng SP, Zelikoff JT (2009) Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 14(suppl 1):97–101
Dong GH, Wang D, Yang ZH, Zhang PF, Ren WH, Zhao YD, He QC (2011) Gender-specific differences in effects of prenatal and postnatal environmental tobacco smoke exposure on respiratory symptoms in 23,474 children with and without allergic predisposition: results from 25 districts of northeast China. Int J Environ Health Res 21(3):173–188
Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL, COPDGene Investigators (2011) Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 184(4):414–420
Forey BA, Thornton AJ, Lee PN (2011) Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 11:36
Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C (2004) COPD in Japan: the Nippon COPD Epidemiology study. Respirology 9(4):458–465
Gardner RM, Nyland JF, Silva IA, Ventura AM, de Souza JM, Silbergeld EK (2010) Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environ Res 110(4):345–354
Georas SN, Guo J, De Fanis U, Casolaro V (2005) T-helper cell type-2 regulation in allergic disease. Eur Respir J 26(6):1119–1137
Gershon AS, Warner L, Cascagnette P, Victor JC, To T (2011) Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 378(9795):991–996
Ghazeeri G, Abdullah L, Abbas O (2011) Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol 66(3):163–169
Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ (2007) Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 176(12):1179–1184
Harrison OJ, Maloy KJ (2011) Innate immune activation in intestinal homeostasis. J Innate Immun 3:585–593
Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jørgensen E (2006) Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med 3(8):e311
Heilmann C, Budtz-Jørgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P (2010) Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect 118(10):1434–1438
Hennessy EJ, Parker AE, O’Neill LA (2010) Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9(4):293–307
House RV, Selgrade MJ (2010) A quarter-century of immunotoxicology: looking back, looking forward. Toxicol Sci 118(1):1–3
Huang W, Glass CK (2010) Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol 30(8):1542–1549
Ionita MG, Arslan F, de Kleijn DP, Pasterkamp G (2010) Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease. J Innate Immun 2(4):307–315
Keogh B, Parker AE (2011) Toll-like receptors as targets for immune disorders. Trends Pharmacol Sci 32(7):435–442
Kerkhof M, Postma DS, Brunekreef B, Reijmerink NE, Wijga AH, de Jongste JC et al (2010) Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 65:690–697
Kiyohara C, Ohno Y (2010) Sex differences in lung cancer susceptibility: a review. Gend Med 7(5):381–401
Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, Takahashi H, Kobashi G, Kyushu Sapporo SLE (KYSS) Study Group (2009) Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Lupus 18(7):630–638
Leifer C, Dietert RR (2011) Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease. Toxicol Environ Chem 93(7):1463–1485
Lin Q, Li M, Fang D, Fang J, Su SB (2011) The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. Int Immunopharmacol 11(10):1422–1432
Luebke R, House R, Kimber I (2007) Immunotoxicology and Immunopharmacology, 3rd edn. CRC Press, Boca Raton
Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI, Immunotoxicology Workgroup (2006) The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev 9(1):1–26
Maezawa Y, Nakajima H, Seto Y, Suto A, Kumano K, Kubo S, Karasuyama H, Saito Y, Iwamoto I (2004) IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways. Clin Exp Immunol 135(1):12–18
Magnusson RS (2009) Rethinking global health challenges: towards a ‘global compact’ for reducing the burden of chronic disease. Public Health 123(3):265–274
Mai J, Wang H, Yang XF (2010) Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci 15:986–1006
Martino DJ, Tulic MK, Gordon L, Hodder M, Richman T, Metcalfe J, Prescott SL, Saffery R (2011) Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics 6(9):1085–1094
Meda F, Folci M, Baccarelli A, Selmi C (2011) The epigenetics of autoimmunity. Cell Mol Immunol 8(3):226–236
Mouihate A, Galic MA, Ellis SL, Spencer SJ, Tsutsui S, Pittman QJ (2010) Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways. J Neurosci 30(23):7975–7983
Ohar J, Fromer L, Donohue JF (2011) Reconsidering sex-based stereotypes of COPD. Prim Care Respir J 20(4):370–378. doi:10.4104/pcrj.2011.00070
Oren A, Vos LE, Uiterwaal CS, Grobbee DE, Bots ML (2003) Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med 163(15):1787–1792
Pascual M, Suzuki M, Isidoro-Garcia M, Padrón J, Turner T, Lorente F, Dávila I, Greally JM (2011) Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma. Epigenetics 6(9):1131–1137
Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, Mohan V, Prabhakaran D, Ravindran RD, Reddy KS (2011) Chronic diseases and injuries in India. Lancet 377(9763):413–428
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE (2008) Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104(1):144–154
Pfefferle PI, Pinkenburg O, Renz H (2010) Fetal epigenetic mechanisms and innate immunity in asthma. Curr Allergy Asthma Rep 10(6):434–443
Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, Dias KR, Bell CG, Tost J, Boehm BO, Beck S, Leslie RD (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7(9):e1002300
Rocha VZ, Folco EJ (2011) Inflammatory concepts of obesity. Int J Inflam 2011:529061
Rooney AA, Matulka RA, Luebke RW (2003) Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. Toxicol Sci 76(2):366–375
Rowe AM, Brundage KM, Schafer R, Barnett JB (2006) Immunomodulatory effects of maternal atrazine exposure on male Balb/c mice. Toxicol Appl Pharmacol 214(1):69–77
Sadeghnejad A, Karmaus W, Arshad SH, Kurukulaaratchy R, Huebner M, Ewart S (2008) IL13 gene polymorphisms modify the effect of exposure to tobacco smoke on persistent wheeze and asthma in childhood, a longitudinal study. Respir Res 9:2
Schaible TD, Harris RA, Dowd SE, Smith CW, Kellermayer R (2011) Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 20(9):1687–1696
Schertzer JD, Tamrakar AK, Magalhães JG, Pereira S, Bilan PJ, Fullerton MD, Liu Z, Steinberg GR, Giacca A, Philpott DJ, Klip A (2011) NOD1 activators link innate immunity to insulin resistance. Diabetes 60(9):2206–2215
Schröder NW (2009) The role of innate immunity in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol 9(1):38–43
Selgrade MK, Lemanske RF Jr, Gilmour MI, Neas LM, Ward MD, Henneberger PK, Weissman DN, Hoppin JA, Dietert RR, Sly PD, Geller AM, Enright PL, Backus GS, Bromberg PA, Germolec DR, Yeatts KB (2006) Induction of asthma and the environment: what we know and need to know. Environ Health Perspect 114(4):615–619
Selmi C, Mix E, Zettl UK (2012) A clear look at the neuroimmunology of multiple sclerosis and beyond. Autoimmun Rev 11(13):159–162. doi:10.1016/j.autrev.2doi:10.1016/j.autrev.2011.05.006011.05.006
Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R (2011) Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 80(11):1231–1238. doi:10.1038/ki.2011.283
Skinner MK, Manikkam M, Guerrero-Bosagna C (2010) Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 21(4):214–222
Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norbäck D, Raherison C, Villani S, Wjst M, Svanes K, Antó JM (2010) Early life origins of chronic obstructive pulmonary disease. Thorax 65(1):14–20
Tsai CH, Tung KY, Chen CH, Lee YL (2011) Tumour necrosis factor G-308A polymorphism modifies the effect of home dampness on childhood asthma. Occup Environ Med 68(10):771–776. doi:10.1136/oem.2010.060970
Van Loveren H, Steerenberg PA, Vos JG (1995) Early detection of immunotoxicity: from animal studies to human biomonitoring. Toxicol Lett 77(1–3):73–80
Wang IJ, Hsieh WS, Wu KY, Guo YL, Hwang YH, Jee SH, Chen PC (2008) Effect of gestational smoke exposure on atopic dermatitis in the offspring. Pediatr Allergy Immunol 19(7):580–586
Werts C, Rubino S, Ling A, Girardin SE, Philpott DJ (2011) Nod-like receptors in intestinal homeostasis, inflammation, and cancer. J Leukoc Biol 90(3):471–482
Wilson AG (2008) Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontal 79(8 suppl):1514–1519
World Health Organization (2011) Global status report on NCDs 2010. World Health Organization Publications, Geneva
Yang ZY, Yang Z, Zhu L, Qiu C (2011) Human behaviors determine health: strategic thoughts on the prevention of chronic non-communicable diseases in China. Int J Behav Med 18(4):295–301
Acknowledgments
The authors thank Janice Dietert for her editorial suggestions and Drs. Christal Bowman and Marc Williams for helpful scientific review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Disclaimer
This paper has been reviewed by the Environmental Protection Agency’s Office of Research and Development and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Dietert, R.R., Luebke, R.W. (2012). The Environment-Immune Route to Chronic Disease. In: Dietert, R., Luebke, R. (eds) Immunotoxicity, Immune Dysfunction, and Chronic Disease. Molecular and Integrative Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-812-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-61779-812-2_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-811-5
Online ISBN: 978-1-61779-812-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)